MedTrace Logo

Pregabalin for Alcohol Dependence

NCT02205879 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-04-07

No results posted yet for this study

Summary

The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity

Conditions

  • Alcoholism

Interventions

DRUG

Pregabalin

DRUG

Placebo

Sponsors & Collaborators

  • St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation

    collaborator UNKNOWN

  • St. Petersburg Bekhterev Research Psychoneurological Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205879 on ClinicalTrials.gov